LSU Stanley S. Scott Cancer Center | Strategic Alliance Partners

Latest from LSU Stanley S. Scott Cancer Center


Novel Agents Signal Progress in the Management of Platinum-Resistant Ovarian Cancer

October 15, 2015

The evaluation of noncytotoxic agents for the treatment of epithelial ovarian cancer has produced encouraging findings in recent months, which has led to the approval of new agents with novel mechanisms of action and continuing studies into many more potential therapies.

x